Center for Quality Aging, Vanderbilt University Medical Center, Nashville, Tennessee.
Geriatric Research, Education, and Clinical Center, Department of Veterans Affairs Medical Center, Tennessee Valley Health Care Center, Nashville, Tennessee.
J Am Geriatr Soc. 2019 Nov;67(11):2387-2392. doi: 10.1111/jgs.16156. Epub 2019 Sep 10.
Polypharmacy is associated with delirium, but the mechanisms for this connection are unclear. Our goal was to determine the frequency of supratherapeutic psychotropic drug levels (SPDLs) in older hospitalized patients and if it is associated with the duration of emergency department (ED) delirium.
Secondary analysis of a prospective cohort study.
Tertiary care academic medical center.
ED patients 65 years or older who were admitted to the hospital.
Delirium was assessed in the ED and during the first 7 days of hospitalization using the modified Brief Confusion Assessment Method. Drug concentrations were determined in serum samples collected at enrollment via a novel platform based on liquid chromatography-tandem mass spectrometry capable of identifying and quantitating 78 clinically approved medications including opioids, benzodiazepines, antidepressants, antipsychotics, and amphetamines. Patients with serum psychotropic drug concentrations above established reference ranges were considered supratherapeutic and have a SPDL. We performed proportional odds logistic regression to determine if SPDLs were associated with ED delirium duration adjusted for confounders. Medical record review was performed to determine if the doses of medications associated with SPDLs were adjusted at hospital discharge.
A total of 158 patients were enrolled; of these, 66 were delirious in the ED. SPDLs were present in 11 (17%) of the delirious and 4 (4%) of the non-delirious ED patients. SPDLs were significantly associated with longer ED delirium duration (adjusted proportional odds ratio = 6.0; 95% confidence interval = 2.1-17.3) after adjusting for confounders. Of the 15 medications associated with SPDLs, 9 (60%) were prescribed at the same or higher doses at the time of hospital discharge.
SPDLs significantly increased the odds of prolonged ED delirium episodes. Approximately half of the medications associated with SPDLs were continued after hospital discharge at the same or higher doses. J Am Geriatr Soc 67:2387-2392, 2019.
药物的联合使用与谵妄有关,但二者之间的联系机制尚不清楚。本研究旨在确定老年住院患者中超治疗性精神药物水平(SPDLs)的发生频率,以及其是否与急诊(ED)谵妄的持续时间有关。
前瞻性队列研究的二次分析。
三级护理学术医疗中心。
年龄在 65 岁或以上且被收入院的 ED 患者。
使用改良的简短谵妄评估方法在 ED 和住院的前 7 天内评估谵妄。通过基于液相色谱-串联质谱的新型平台在入组时采集血清样本以确定药物浓度,该平台能够鉴定和定量分析 78 种临床批准的药物,包括阿片类药物、苯二氮䓬类药物、抗抑郁药、抗精神病药和安非他命。将血清精神药物浓度高于既定参考范围的患者视为超治疗性,且存在 SPDL。我们进行了比例优势比逻辑回归分析,以确定 SPDLs 是否与调整混杂因素后的 ED 谵妄持续时间相关。进行病历回顾以确定与 SPDLs 相关的药物剂量是否在出院时进行了调整。
共纳入 158 例患者,其中 66 例在 ED 时出现谵妄。在谵妄患者中有 11 例(17%)和非谵妄 ED 患者中有 4 例(4%)存在 SPDLs。在调整混杂因素后,SPDLs 与 ED 谵妄持续时间延长显著相关(调整后的比例优势比=6.0;95%置信区间=2.1-17.3)。在与 SPDLs 相关的 15 种药物中,有 9 种(60%)在出院时以相同或更高的剂量开具。
SPDLs 显著增加了 ED 谵妄发作时间延长的几率。与 SPDLs 相关的药物中,约有一半在出院时以相同或更高的剂量继续使用。
补充说明:这是一篇医学论文,术语较多,在翻译时要尤其注意。